Common clinical indications

• Active immunization of infants 6 weeks to 15 months of age born to HBsAg-negative mothers against invasive disease caused by Haemophilus influenzae type b
• Active immunization of infants 6 weeks to 15 months of age born to HBsAg-negative mothers against infection caused by all known subtypes of hepatitis B virus when hepatitis B vaccination is also indicated
• Use as part of the routine childhood immunization program where combination Hib/HepB vaccination is appropriate per current AAP/ACIP guidance

Related drugs in this category

• Hepatitis B Vaccine (Recombinant) · Hepatitis B Vaccine (Recombinant)

Frequently asked questions

What is Hib Conjugate/Hepatitis B Combination Vaccine used for?

Hib Conjugate/Hepatitis B Combination Vaccine (Haemophilus influenzae type b conjugate and Hepatitis B vaccine (Comvax)) is listed in YMed Atlas under Vaccine. Indications, dosing, and safety information on this page summarize curated references—always confirm with current labeling, formularies, and local protocols.

How do I adjust dosing for renal impairment or special populations?

Review the dosing sections and references for this monograph. Many agents require renal or hepatic adjustment; pediatric, pregnancy, and lactation considerations are clinician-specific. This interface is educational and does not replace individualized prescribing decisions.

Is this medical advice?

No. YMed Atlas drug pages support learning and quick reference. They are not a substitute for clinical judgment, pharmacist review, or formal interaction checking with a complete medication list.